{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:51:50Z","timestamp":1788565910511,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.4158\/ep161476.or","type":"journal-article","created":{"date-parts":[[2016,11,7]],"date-time":"2016-11-07T12:46:24Z","timestamp":1478522784000},"page":"157-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Nephrolithiasis in Primary Hyperparathyroidism: A Comparison Between Silent and Symptomatic Patients"],"prefix":"10.1016","volume":"23","author":[{"given":"Elena","family":"Castellano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Attanasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Latina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian L.","family":"Visconti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Cassibba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Borretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP161476.OR_bb0010","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1210\/jc.2011-0569","article-title":"Nephrolithiasis and renal calcifications in primary hyperparathyroidism","volume":"96","author":"Rejnmark","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161476.OR_bb0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00240-007-0096-2","article-title":"Biochemical characterization of primary hyperparathyroidism with and without kidney stones","volume":"35","author":"Odvina","year":"2007","journal-title":"Urol Res"},{"key":"10.4158\/EP161476.OR_bb0020","doi-asserted-by":"crossref","first-page":"908","DOI":"10.2214\/AJR.07.3160","article-title":"Primary hyperparathyroidism: is there an increased prevalence of renal stone disease?","volume":"191","author":"Suh","year":"2008","journal-title":"AJR Amer J Roentgenol"},{"key":"10.4158\/EP161476.OR_bb0025","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4158\/EP14074.OR","article-title":"Silent renal stones in primary hyperparathyroidism: prevalence and clinical features","volume":"20","author":"Cassibba","year":"2014","journal-title":"Endocr Pract"},{"key":"10.4158\/EP161476.OR_bb0030","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/jc.2014-3708","article-title":"Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology","volume":"100","author":"Cipriani","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161476.OR_bb0035","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161476.OR_bb0040","first-page":"1","article-title":"2013 KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.4158\/EP161476.OR_bb0045","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.jhh.1002201","article-title":"Validity and reproducibility of HOMA-IR, 1\/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes","volume":"21","author":"Sarafidis","year":"2007","journal-title":"J Hum Hypertens"},{"key":"10.4158\/EP161476.OR_bb0050","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.urology.2014.01.016","article-title":"Determinants of urolithiasis before and after parathyroidectomy in patients with primary hyperparathyroidism","volume":"84","author":"Elkoushy","year":"2014","journal-title":"Urology"},{"key":"10.4158\/EP161476.OR_bb0055","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1530\/EJE-12-0032","article-title":"Renal stones and calcifications in patients with primary hyperparathyroidism: associations with biochemical variables","volume":"166","author":"Starup-Linde","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP161476.OR_bb0060","doi-asserted-by":"crossref","first-page":"D13","DOI":"10.1530\/EJE-15-0277","article-title":"Is surgery necessary for \u2018mild\u2019 or \u2018asymptomatic\u2019 hyperparathyroidism?","volume":"173","author":"Niederle","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP161476.OR_bb0065","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1210\/jc.2013-3978","article-title":"Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial","volume":"99","author":"Rolighed","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161476.OR_bb0070","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ucl.2007.04.009","article-title":"Pathophysiology and management of calcium stones","volume":"34","author":"Park","year":"2007","journal-title":"Urol Clin North Am"},{"key":"10.4158\/EP161476.OR_bb0075","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ki.2008.626","article-title":"Recent advances in the pathophysiology of nephrolithiasis","volume":"75","author":"Sakhaee","year":"2009","journal-title":"Kidney Int"},{"key":"10.4158\/EP161476.OR_bb0080","first-page":"N87","article-title":"Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum","volume":"17","author":"Peacock","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP161476.OR_bb0085","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF03345354","article-title":"Risk factors associated to kidney stones in primary hyperparathyroidism","volume":"28","author":"Corbetta","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"10.4158\/EP161476.OR_bb0090","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0039-6060(96)80051-1","article-title":"Characteristics of patients surgically treated for primary hyperparathyroidism with and without renal stones","volume":"120","author":"S\u00f6reide","year":"1996","journal-title":"Surgery"},{"key":"10.4158\/EP161476.OR_bb0095","article-title":"Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism","author":"Viccica","year":"2016","journal-title":"Endocrine"},{"key":"10.4158\/EP161476.OR_bb0100","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/cen.12210","article-title":"Vitamin D status in primary hyperparathyroidism: a Southern European perspective","volume":"79","author":"Tassone","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161476.OR_bb0105","first-page":"1054","article-title":"Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications","volume":"85","author":"Rao","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161476.OR_bb0110","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0002-9343(99)00294-6","article-title":"The effects of vitamin D insufficiency in patients with primary hyperparathyroidism","volume":"107","author":"Silverberg","year":"1999","journal-title":"Am J Med"},{"key":"10.4158\/EP161476.OR_bb0115","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/BF03344140","article-title":"A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism","volume":"29","author":"Boudou","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"10.4158\/EP161476.OR_bb0120","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejim.2011.07.008","article-title":"Vitamin D status in primary hyperparathyroidism","volume":"23","author":"Saliba","year":"2012","journal-title":"Eur J Intern Med"},{"key":"10.4158\/EP161476.OR_bb0125","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJM198002213020801","article-title":"The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism","volume":"302","author":"Broadus","year":"1980","journal-title":"N Engl J Med"},{"key":"10.4158\/EP161476.OR_bb0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2265.2006.02680.x","article-title":"Plasma 1,25-dihydroxyvitamin-D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function","volume":"66","author":"Moosgaard","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161476.OR_bb0135","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/ki.1987.125","article-title":"Renal mass and reserve of vitamin D: determinants in primary hyperparathyroidism","volume":"31","author":"Patron","year":"1987","journal-title":"Kidney Int"},{"key":"10.4158\/EP161476.OR_bb0140","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2265.2005.02371.x","article-title":"Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism","volume":"63","author":"Moosgaard","year":"2005","journal-title":"Clin Endocrinol"},{"key":"10.4158\/EP161476.OR_bb0145","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1111\/j.1523-1755.2004.00975.x","article-title":"Rapid Communication: relative effect of urinary calcium and oxalate on saturation of calcium oxalate","volume":"66","author":"Pak","year":"2004","journal-title":"Kidney Int"},{"key":"10.4158\/EP161476.OR_bb0150","doi-asserted-by":"crossref","first-page":"e0137350","DOI":"10.1371\/journal.pone.0137350","article-title":"Altered calcium and vitamin D homeostasis in first-time calcium kidney stone-formers","volume":"10","author":"Ketha","year":"2015","journal-title":"PLoS One"},{"key":"10.4158\/EP161476.OR_bb0155","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12020-009-9211-1","article-title":"Biochemical effects of calcifediol supplementation in mild, asymptomatic, hyperparathyroidism with concomitant vitamin D deficiency","volume":"36","author":"Isidro","year":"2009","journal-title":"Endocrine"},{"key":"10.4158\/EP161476.OR_bb0160","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1530\/EJE-08-0901","article-title":"Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D","volume":"161","author":"Tucci","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP161476.OR_bb0165","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1210\/jc.2004-1772","article-title":"Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency","volume":"90","author":"Grey","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161476.OR_bb0170","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00240-008-0161-5","article-title":"Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers","volume":"36","author":"Negri","year":"2008","journal-title":"Urol Res"},{"key":"10.4158\/EP161476.OR_bb0175","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1530\/EJE-10-0915","article-title":"Polymorphisms at the regulatory regions of the CASR gene influence stone risk in primary hyperparathyroidism","volume":"164","author":"Vezzoli","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP161476.OR_bb0180","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1097\/01.ASN.0000030077.72157.D2","article-title":"Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients","volume":"13","author":"Vezzoli","year":"2002","journal-title":"J Am Soc Nephrol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20355518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20355518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:02:52Z","timestamp":1761516172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20355518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1530891X20355518"],"URL":"https:\/\/doi.org\/10.4158\/ep161476.or","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nephrolithiasis in Primary Hyperparathyroidism: A Comparison Between Silent and Symptomatic Patients","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP161476.OR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}